| 1 |
Measurement of tissue factor-positive extracellular vesicles in plasma: strengths and weaknesses of current methods |
|
| | Nigel Mackman, Ana Teresa Azevedo Sachetto, Yohei Hisada | | | Current Opinion in Hematology. 2022; Publish Ah | | | [Pubmed] [Google Scholar] | | | 2 |
Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency |
|
| | Hassan A Hamali, Muhammad Saboor, Gasim Dobie, Aymen M Madkhali, Mohammad S Akhter, Ali Hakamy, Hesham M Al-Mekhlafi, Denise E Jackson, Yahya H Matari, Abdullah A Mobarki | | | Infection and Drug Resistance. 2022; Volume 15: 2359 | | | [Pubmed] [Google Scholar] | | | 3 |
Elevated levels of procoagulant microvesicles in patients with dengue fever |
|
| | Hassan A Hamali,Abdullah A Mobarki,Mohammad S Akhter,Muhammad Saboor,Aymen M Madkhali,Amr J Halawani,Abdulaziz M Hakami,Zaki M Eisa,Gasim Dobie,Yahya Hobani | | | Future Virology. 2020; | | | [Pubmed] [Google Scholar] | | | 4 |
Measurement of extracellular vesicles as biomarkers of consequences or cause complications of pathological states, and prognosis of both evolution and therapeutic safety/efficacy |
|
| | Jean Amiral,Jerard Seghatchian | | | Transfusion and Apheresis Science. 2016; | | | [Pubmed] [Google Scholar] | |
|
